Nalaganje...
Hemophilia gene therapy comes of age
Concurrent with the development of recombinant factor replacement products, the characterization of the F9 and F8 genes over 3 decades ago allowed for the development of recombinant factor products and made the hemophilias a target disease for gene transfer. The progress of hemophilia gene therapy h...
Shranjeno v:
| izdano v: | Blood Adv |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5728634/ https://ncbi.nlm.nih.gov/pubmed/29296912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017009878 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|